Tirzepatide 10mg

Tirzepatide is a synthetic dual agonist targeting both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor, representing a novel therapeutic approach in metabolic research. It exhibits an imbalanced pharmacological profile with greater affinity and potency at the GIP receptor, while still activating the GLP-1 receptor to promote glucose-dependent insulin secretion and improve metabolic regulation. This dual receptor activation contributes to enhanced glycemic control, appetite suppression, and potential weight management benefits, making tirzepatide a significant molecule in diabetes and obesity research.